66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - General
Funcionários Integrais: 88.000
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Dr. Albert Bourla D.V.M., Ph.D. | Chairman of the Board & CEO | 4,05M | N/A | 1962 |
Mr. David M. Denton | Chief Financial Officer & Executive VP | 1,75M | N/A | 1965 |
Dr. Mikael Dolsten M.D., Ph.D. | Chief Scientific Officer and President of Research & Development | 2,41M | N/A | 1958 |
Mr. Douglas M. Lankler | Executive VP & General Counsel | 1,76M | N/A | 1966 |
Mr. Aamir Malik | Executive VP & Chief U.S. Commercial Officer | 1,89M | N/A | 1976 |
Ms. Jennifer B. Damico | Senior VP, Controller & Principal Accounting Officer | N/A | N/A | 1968 |
Ms. Lidia L. Fonseca | Executive VP and Chief Digital & Technology Officer | N/A | N/A | 1969 |
Ms. Francesca M. DeMartino | Chief Investor Relations Officer | N/A | N/A | N/A |
Mr. Rady A. Johnson | Executive VP and Chief Compliance, Quality & Risk Officer | N/A | N/A | 1962 |
Mr. Andreas J. Panayiotou | Global Chief Marketing Officer | N/A | N/A | N/A |
O QualityScore de governança da ISS da Pfizer Inc. a partir de 1 de abril de 2024 é 5. As principais pontuações para Auditoria são: 10; Conselho: 6; Direitos de Acionistas: 1; Compensação: 3.